Cancer as an evolutionary and ecological process (original) (raw)

• Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976). The seminal description of cancer as an evolutionary process. Predicts sequences of clonal expansions, individual variation in response to interventions and therapeutic resistance.
  Article CAS PubMed Google Scholar
• Crespi, B. & Summers, K. Evolutionary Biology of Cancer. Trends Ecol. Evol. 20, 545–552 (2005).
  Article PubMed Google Scholar
• Heppner, G. & Miller, F. The cellular basis of tumor progression. Int. Rev. Cytol. 177, 1–56 (1998).
  CAS PubMed Google Scholar
• Cairns, J. Mutation selection and the natural history of cancer. Nature 255, 197–200 (1975). Highlights the interaction between tissue architecture and clonal evolution. Also predicts the retention of a non-recombining, 'immortal' strand of DNA in stem cells.
  Article CAS PubMed Google Scholar
• Tsao, J. L. et al. Genetic reconstruction of individual colorectal tumor histories. Proc. Natl Acad. Sci. USA 97, 1236–1241 (2000). Uses phylogenetic methods to trace the common ancestor of microsatellite-unstable clones in colorectal cancer back to a date before an adenoma was detected.
  Article CAS PubMed PubMed Central Google Scholar
• Tsao, J. L. et al. Colorectal adenoma and cancer divergence. Evidence of multilineage progression. Am. J. Pathol. 154, 1815–1824 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Michor, F., Iwasa, Y. & Nowak, M. A. Dynamics of cancer progression. Nature Rev. Cancer 4, 197–205 (2004).
  Article CAS Google Scholar
• Maley, C. C. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genet. 38, 468–473 (2006). Shows that genetic diversity measures from ecology and evolution predict progression to malignancy.
  Article CAS PubMed Google Scholar
• Maley, C. C. & Reid, B. J. Natural selection in neoplastic progression of Barrett's esophagus. Semin. Cancer Biol. 15, 474–483 (2005).
  Article CAS PubMed Google Scholar
• Maley, C. C., Reid, B. J. & Forrest, S. Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. Cancer Epidemiol. Biomarkers Prev. 13, 1375–1384 (2004). Uses computational models to develop prevention and therapeutic strategies for avoiding the evolution of resistance.
  PubMed Google Scholar
• Tomlinson, I. P. M. Game-theory models of interactions between tumour cells. Euro. J. Cancer 33, 1495–1500 (1997).
  Article CAS Google Scholar
• Gatenby, R. A. & Vincent, T. L. Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. Mol. Cancer Ther. 2, 919–927 (2003). Describes the use of evolutionary and ecological models to develop new approaches to therapy.
  CAS PubMed Google Scholar
• Gonzalez-Garcia, I., Sole, R. V. & Costa, J. Metapopulation dynamics and spatial heterogeneity in cancer. Proc. Natl Acad. Sci. USA 99, 13085–13089 (2002). Shows genetic heterogeneity within a neoplasm, and how clones can be intertwined in complex patterns.
  Article CAS PubMed PubMed Central Google Scholar
• Brash, D. E., Zhang, W., Grossman, D. & Takeuchi, S. Colonization of adjacent stem cell compartments by mutant keratinocytes. Semin. Cancer Biol. 15, 97–102 (2005).
  Article CAS PubMed Google Scholar
• Braakhuis, B. J., Leemans, C. R. & Brakenhoff, R. H. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin. Cancer Biol. 15, 113–120 (2005).
  Article PubMed Google Scholar
• Maley, C. C. et al. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res. 64, 3414–3427 (2004).
  Article CAS PubMed Google Scholar
• Franklin, W. A. et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field car-cinogenesis. J. Clin. Invest. 100, 2133–2137 (1997). Shows that neoplastic clones can spread over large surface areas.
  Article CAS PubMed PubMed Central Google Scholar
• Castro, M. A., Onsten, T. T., de Almeida, R. M. & Moreira, J. C. Profiling cytogenetic diversity with entropy-based karyotypic analysis. J. Theor. Biol. 234, 487–495 (2005).
  Article CAS PubMed Google Scholar
• Keller, L. K. Levels of Selection in Evolution (Princeton University Press, Princeton, New Jersey, 1999).
  Google Scholar
• Leroi, A. M., Koufopanou, V. & Burt, A. Cancer selection. Nature Rev. Cancer 3, 226–231 (2003).
  Article CAS Google Scholar
• Weinstein, B. S. & Ciszek, D. The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair. Exp. Gerontol. 37, 615–627 (2002).
  Article CAS PubMed Google Scholar
• Frank, S. A. & Nowak, M. A. Problems of somatic mutation and cancer. Bioessays 26, 291–299 (2004).
  Article CAS PubMed Google Scholar
• Campisi, J. Aging, tumor suppression and cancer: high wire-act! Mech. Ageing Dev. 126, 51–58 (2005).
  Article CAS PubMed Google Scholar
• Summers, K., da Silva, J. & Farwell, M. Intragenomic conflict and cancer. Med. Hypotheses 59, 170–179 (2002).
  Article CAS PubMed Google Scholar
• Roth, M. J. et al. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma. Cancer Res. 61, 4098–4104 (2001).
  CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS PubMed Google Scholar
• Stoler, D. L. et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl Acad. Sci. USA 96, 15121–15126 (1999). Measures the frequency of genomic alterations in colorectal cancer at approximately 11,000 per clone.
  Article CAS PubMed PubMed Central Google Scholar
• Sole, R. V. & Deisboeck, T. S. An error catastrophe in cancer? J. Theor. Biol. 228, 47–54 (2004).
  Article PubMed Google Scholar
• Breivik, J. The evolutionary origin of genetic instability in cancer development. Semin. Cancer Biol. 15, 51–60 (2005).
  Article CAS PubMed Google Scholar
• Michor, F., Iwasa, Y., Vogelstein, B., Lengauer, C. & Nowak, M. A. Can chromosomal instability initiate tumorigenesis? Semin. Cancer Biol. 15, 43–49 (2005).
  Article CAS PubMed Google Scholar
• Rajagopalan, H., Nowak, M. A., Vogelstein, B. & Lengauer, C. The significance of unstable chromosomes in colorectal cancer. Nature Rev. Cancer 3, 695–701 (2003).
  Article CAS Google Scholar
• Gray, M. W., Burger, G. & Lang, B. F. Mitochondrial evolution. Science 283, 1476–1481 (1999).
  Article CAS PubMed Google Scholar
• Baylin, S. B. & Herman, J. G. DNA hypermethylation in tumorigenesis- epigenetics joins genetics. Trends Genet. 16, 168–174 (2000).
  CAS PubMed Google Scholar
• Feinberg, A. P., Ohlsson, R. & Henikoff, S. The epigenetic progenitor origin of human cancer. Nature Rev. Genet. 7, 21–33 (2006).
  Article CAS PubMed Google Scholar
• Weisenberger, D. J. et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genet. 38, 787–793 (2006).
  Article CAS PubMed Google Scholar
• Horie-Inoue, K. & Inoue, S. Epigenetic and proteolytic inactivation of 14–3-3sigma in breast and prostate cancers. Semin. Cancer Biol. 16, 235–239 (2006).
  Article CAS PubMed Google Scholar
• Albertini, R. J., Nicklas, J. A., O'Neill, J. P. & Robison, S. H. In vivo somatic mutations in humans: measurement and analysis. Annu. Rev. Genet. 24, 305–326 (1990).
  Article CAS PubMed Google Scholar
• Araten, D. J. et al. A quantitative measurement of the human somatic mutation rate. Cancer Res. 65, 8111–8117 (2005).
  Article CAS PubMed Google Scholar
• Sniegowski, P. D., Gerrish, P. J., Johnson, T. & Shaver, A. The evolution of mutation rates: separating causes from consequences. Bioessays 22, 1057–1066 (2000).
  Article CAS PubMed Google Scholar
• Sniegowski, P. D., Gerrish, P. J. & Lenski, R. E. Evolution of high mutation rates in experimental populations of E. coli. Nature 387, 703–705 (1997).
  Article CAS PubMed Google Scholar
• Dyer, M. A. & Bremner, R. The search for the retinoblastoma cell of origin. Nature Rev. Cancer 5, 91–101 (2005).
  Article Google Scholar
• Renan, M. J. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol. Carcinogenesis 7, 139–146 (1993).
  Article CAS Google Scholar
• Nunney, L. The population genetics of multistage carcinogenesis. Proc. Biol. Sci. 270, 1183–1191 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075–3079 (1991). Shows that the background mutation rate is not adequate to explain carcinogenesis, and proposes that genetic instability might be necessary for cancer to develop.
  CAS PubMed Google Scholar
• Tomlinson, I. & Bodmer, W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Med. 5, 11–12 (1999).
  Article CAS PubMed Google Scholar
• Moolgavkar, S. H. & Luebeck, E. G. Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer 38, 302–306 (2003).
  Article CAS PubMed Google Scholar
• Loeb, K. R. & Loeb, L. A. Significance of multiple muta-tions in cancer. Carcinogenesis 21, 379–385 (2000).
  Article CAS PubMed Google Scholar
• Maley, C. C. et al. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 64, 7629–7633 (2004).
  Article CAS PubMed Google Scholar
• Ohta, T. Slightly deleterious mutant substitutions in evolution. Nature 246, 96–98 (1973).
  Article CAS PubMed Google Scholar
• Huntly, B. J. & Gilliland, D. G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nature Rev. Cancer 5, 311–321 (2005).
  Article CAS Google Scholar
• Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J. & Maitland, N. J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946–10951 (2005).
  Article CAS PubMed Google Scholar
• Sell, S. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environ. Health Perspect. 101, 15–26 (1993).
  Article PubMed PubMed Central Google Scholar
• Potten, C. S., Booth, C. & Pritchard, D. M. The intestinal epithelial stem cell: the mucosal governor. Int. J. Exp. Pathol. 78, 219–243 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Michor, F., Frank, S. A., May, R. M., Iwasa, Y. & Nowak, M. A. Somatic selection for and against cancer. J. Theor. Biol. 225, 377–382 (2003).
  Article CAS PubMed Google Scholar
• Frank, S. A. & Nowak, M. A. Cell biology: developmental predisposition to cancer. Nature 422, 494 (2003).
  Article CAS PubMed Google Scholar
• Meza, R., Luebeck, E. G. & Moolgavkar, S. H. Gestational mutations and carcinogenesis. Math. Biosci. 197, 188–210 (2005).
  Article CAS PubMed Google Scholar
• Maynard Smith, J. & Haigh, J. The hitch-hiking effect of a favorable gene. Genet. Res. 231, 1114–1116 (1974).
  Google Scholar
• Lewontin, R. C. The Genetic Basis of Evolutionary Change (Columbia University Press, New York, 1970).
  Google Scholar
• Braakhuis, B. J., Tabor, M. P., Kummer, J. A., Leemans, C. R. & Brakenhoff, R. H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 63, 1727–1730 (2003).
  CAS PubMed Google Scholar
• Chao, E. C. & Lipkin, S. M. Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res. 34, 840–852 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
  Article CAS PubMed Google Scholar
• Desper, R. et al. Inferring tree models for oncogenesis from comparative genome hybridization data. J. Comput. Biol. 37–51 (1999).
• Smith, G. et al. Mutations in APC, Kirsten-ras, and p53 — alternative genetic pathways to colorectal cancer. Proc. Natl Acad. Sci. USA 99, 9433–9438 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kobayashi, S. et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 352, 786–792 (2005).
  Article CAS PubMed Google Scholar
• Gorre, M. E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876–880 (2001).
  Article CAS PubMed Google Scholar
• Wang, T. L. et al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc. Natl Acad. Sci. USA 101, 3089–3094 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Donnenberg, V. S. & Donnenberg, A. D. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J. Clin. Pharmacol. 45, 872–877 (2005).
  Article CAS PubMed Google Scholar
• Michor, F. et al. Dynamics of chronic myeloid leukaemia. Nature 435, 1267–1270 (2005).
  Article CAS PubMed Google Scholar
• Luria, S. E. & Delbruck, M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491–511 (1943).
  CAS PubMed PubMed Central Google Scholar
• Komarova, N. Stochastic modeling of drug resistance in cancer. J. Theor. Biol. 239, 351–366 (2006).
  Article CAS PubMed Google Scholar
• Roche-Lestienne, C. & Preudhomme, C. Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment. Semin. Hematol. 40, 80–82 (2003).
  Article CAS PubMed Google Scholar
• Iwasa, Y., Nowak, M. A. & Michor, F. Evolution of resistance during clonal expansion. Genetics 172, 2557–2566 (2006).
  Article PubMed PubMed Central Google Scholar
• Knudson, A. G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820–823 (1971). Uses a Poisson model to deduce the requirement of two mutations to generate retinoblastoma.
  Article PubMed PubMed Central Google Scholar
• Etzioni, R. et al. The case for early detection. Nature Rev. Cancer 3, 1–10 (2003).
  Article CAS Google Scholar
• Chabner, B. A. & Roberts, T. G. Jr. Timeline: chemotherapy and the war on cancer. Nature Rev. Cancer 5, 65–72 (2005).
  Article CAS Google Scholar
• Komarova, N. L. & Wodarz, D. Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy. Cancer Res. 63, 6635–6642 (2003).
  CAS PubMed Google Scholar
• Suiter, A. M., Banziger, O. & Dean, A. M. Fitness consequences of a regulatory polymorphism in a seasonal environment. Proc. Natl Acad. Sci. USA 100, 12782–12786 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, J. J. & Tannock, I. F. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nature Rev. Cancer 5, 516–525 (2005).
  Article CAS Google Scholar
• Kern, W. & Estey, E. H. High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: review of three randomized trials. Cancer 107, 116–124 (2006).
  Article CAS PubMed Google Scholar
• Dolken, G. Detection of minimal residual disease. Adv. Cancer Res. 82, 133–185 (2001).
  Article CAS PubMed Google Scholar
• Rubin, C. E. et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 103, 1611–1620 (1992).
  Article CAS PubMed Google Scholar
• Brentnall, T. A. et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107, 369–378 (1994).
  Article CAS PubMed Google Scholar
• van Oijen, M. G. & Slootweg, P. J. Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol. Biomarkers Prev. 9, 249–256 (2000).
  CAS PubMed Google Scholar
• Hunter, K. W. Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination. Cancer Lett. 200, 97–105 (2003).
  Article CAS PubMed Google Scholar
• Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418, 823 (2002).
  Article CAS PubMed Google Scholar
• Bernards, R. & Weinberg, R. A. Bernards and Weinberg reply. Nature 419, 560 (2002).
  Article CAS Google Scholar
• Fidler, I. J. & Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893–895 (1977).
  Article CAS PubMed Google Scholar
• Kirkwood, T. B. Evolution of ageing. Mech. Ageing Dev. 123, 737–745 (2002).
  Article PubMed Google Scholar
• Futuyma, D. J. Evolutionary Biology (Sinauer Associates Inc., Sunderland, Massachusetts, 1998).
  Google Scholar
• Paszek, M. J. et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241–254 (2005).
  Article CAS PubMed Google Scholar
• Vaupel, P. & Mayer, A. Hypoxia and anemia: effects on tumor biology and treatment resistance. Transfus. Clin. Biol. 12, 5–10 (2005).
  Article PubMed Google Scholar
• Cadet, C., Ferriere, R., Metz, J. A. & van Baalen, M. The evolution of dispersal under demographic stochasticity. Am. Nat. 162, 427–441 (2003).
  Article PubMed Google Scholar
• Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Rev. Cancer 3, 453–458 (2003).
  Article CAS Google Scholar
• Kolar, C. S. & Lodge, D. M. Progress in invasion biology: predicting invaders. Trends Ecol. Evol. 16, 199–204 (2001).
  Article PubMed Google Scholar
• Peterson, A. T. Predicting the geography of species' invasions via ecological niche modeling. Q. Rev. Biol. 78, 419–433 (2003).
  Article PubMed Google Scholar
• Shea, K. & Chesson, P. Community ecology theory as a framework for biological invasions. Trends Ecol. Evol. 17, 170–176 (2002).
  Article Google Scholar
• Mable, B. K. Breaking down taxonomic barriers in polyploidy research. Trends Plant Sci. 8, 582–590 (2003).
  Article CAS PubMed Google Scholar
• Otto, S. P. & Whitton, J. Polyploid incidence and evolution. Annu. Rev. Genet. 34, 401–437 (2000).
  Article CAS PubMed Google Scholar
• Imhof, M. & Schlotterer, C. E. coli microcosms indicate a tight link between predictability of ecosystem dynamics and diversity. PLoS Genet. 2, e103 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Heppner, G., Miller, B., Cooper, D. N. & Miller, F. R. in Cell Biology of Breast Cancer (eds McGrath, C. M., Brennan, M. J. & Rich, M. A.) 161–172 (Academic Press, New York, 1980).
  Google Scholar
• Guba, M. et al. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res. 61, 5575–5579 (2001).
  CAS PubMed Google Scholar
• Miller, B. E., Miller, F. R., Leith, J. & Heppner, G. H. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor. Cancer Res. 40, 3977–3981 (1980). Shows that different clones in a neoplasm can affect each other's growth in complex ways.
  CAS PubMed Google Scholar
• Caignard, A., Martin, M. S., Michel, M. F. & Martin, F. Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int. J. Cancer 36, 273–279 (1985).
  Article CAS PubMed Google Scholar
• Bach, L. A., Bentzen, S. M., Alsner, J. & Christiansen, F. B. An evolutionary-game model of tumour-cell interactions: possible relevance to gene therapy. Eur. J. Cancer 37, 2116–2120 (2001).
  Article CAS PubMed Google Scholar
• Gatenby, R. A. & Vincent, T. L. An evolutionary model of carcinogenesis. Cancer Res. 63, 6212–6220 (2003).
  CAS PubMed Google Scholar
• Nagy, J. D. Competition and natural selection in a mathematical model of cancer. Bull. Math. Biol. 66, 663–687 (2004).
  Article PubMed Google Scholar
• Seliger, B. Strategies of tumor immune evasion. BioDrugs 19, 347–354 (2005).
  Article CAS PubMed Google Scholar
• Uhr, J. W., Scheuermann, R. H., Street, N. E. & Vitetta, E. S. Cancer dormancy: opportunities for new therapeutic approaches. Nature Med. 3, 505–509 (1997).
  Article CAS PubMed Google Scholar
• Mitteldorf, J. Chaotic population dynamics and the evolution of aging. Evol. Ecol. Res. 8, 561–574 (2006).
  Google Scholar
• Rundhaug, J. E. Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9, 267–285 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Travisano, M. & Velicer, G. J. Strategies of microbial cheater control. Trends Microbiol. 12, 72–78 (2004).
  Article CAS PubMed Google Scholar
• Turner, P. E. Parasitism between co-infecting bacteriophages. Adv. Ecol. Res. 37, 309–332 (2005).
  Article Google Scholar
• Velicer, G. J., Kroos, L. & Lenski, R. E. Developmental cheating in the social bacterium Myxococcus xanthus. Nature 404, 598–601 (2000).
  Article CAS PubMed Google Scholar
• Jouanneau, J., Moens, G., Bourgeois, Y., Poupon, M. F. & Thiery, J. P. A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression. Proc. Natl Acad. Sci. USA 91, 286–290 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Axelrod, R., Axelrod, D. E. & Pienta, K. J. Evolution of cooperation among tumor cells. Proc. Natl Acad. Sci. USA 103, 13474–13479 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Mueller, M. M. & Fusenig, N. E. Friends or foes- bipolar effects of the tumour stroma in cancer. Nature Rev. Cancer 4, 839–849 (2004).
  Article CAS Google Scholar
• Shao, Z. M., Nguyen, M. & Barsky, S. H. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19, 4337–4345 (2000).
  Article CAS PubMed Google Scholar
• Tlsty, T. D. Stromal cells can contribute oncogenic signals. Semin. Cancer Biol. 11, 97–104 (2001).
  Article CAS PubMed Google Scholar
• Fukino, K. et al. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res. 64, 7231–7236 (2004). Shows that tumour stroma also has genetic lesions, and so must be co-evolving with the epithelium.
  Article CAS PubMed Google Scholar
• Paterson, R. F. et al. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 98, 1830–1836 (2003).
  Article CAS PubMed Google Scholar
• Ishiguro, K., Yoshida, T., Yagishita, H., Numata, Y. & Okayasu, T. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 55, 695–702 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kenny, P. A. & Bissell, M. J. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int. J. Cancer 107, 688–695 (2003).
  CAS PubMed PubMed Central Google Scholar
• Mintz, B. & Illmensee, K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl Acad. Sci. USA 72, 3585–3589 (1975).
  Article CAS PubMed PubMed Central Google Scholar
• Miller, F. R. & Heppner, G. H. Cellular interactions in metastasis. Cancer Metastasis Rev. 9, 21–34 (1990).
  Article CAS PubMed Google Scholar
• Kuperwasser, C. et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA 101, 4966–4971 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Bhowmick, N. A. et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848–851 (2004).
  Article CAS PubMed Google Scholar
• Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005).
  Article CAS PubMed Google Scholar
• Roxburgh, S. H., Shea, K. & Wilson, J. B. The intermediate disturbance hypothesis: patch dynamics and mechanisms of species coexistence. Ecology 85, 359–371 (2004).
  Article Google Scholar
• Bjerkvig, R., Tysnes, B. B., Aboody, K. S., Najbauer, J. & Terzis, A. J. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nature Rev. Cancer 5, 899–904 (2005).
  Article CAS Google Scholar
• Boyer, B., Valles, A. M. & Edme, N. Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 60, 1091–1099 (2000).
  Article CAS PubMed Google Scholar
• Elena, S. F. & Lenski, R. E. Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nature Rev. Genet. 4, 457–469 (2003).
  Article CAS PubMed Google Scholar
• Spencer, S. L., Gerety, R. A., Pienta, K. J. & Forrest, S. Modeling somatic evolution in tumorigenesis. PLoS Comput. Biol. 2, e108 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Drummond, A., Forsberg, R. & Rodrigo, A. G. The inference of stepwise changes in substitution rates using serial sequence samples. Mol. Biol. Evol. 18, 1365–1371 (2001).
  Article CAS PubMed Google Scholar
• Harper, D. M. et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367, 1247–1255 (2006).
  Article CAS PubMed Google Scholar
• Jakobisiak, M., Lasek, W. & Golab, J. Natural mechanisms protecting against cancer. Immunol. Lett. 90, 103–122 (2003).
  Article CAS PubMed Google Scholar
• Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984–2991 (1998).
  Article CAS PubMed Google Scholar
• Michor, F., Nowak, M. A., Frank, S. A. & Iwasa, Y. Stochastic elimination of cancer cells. Proc. Biol. Sci. 270, 2017–2024 (2003).
  Article PubMed PubMed Central Google Scholar
• Torres-Montaner, A. & Hughes, D. A hypothetical anti-neoplastic mechanism associated to reserve cells. J. Theor. Biol. 231, 239–248 (2004).
  Article PubMed Google Scholar
• Frank, S. A., Iwasa, Y. & Nowak, M. A. Patterns of cell division and the risk of cancer. Genetics 163, 1527–1532 (2003).
  PubMed PubMed Central Google Scholar
• Komarova, N. L. & Cheng, P. Epithelial tissue architecture protects against cancer. Math. Biosci. 200, 90–117 (2006).
  Article PubMed Google Scholar
• Nowak, M. A., Michor, F. & Iwasa, Y. The linear process of somatic evolution. Proc. Natl Acad. Sci. USA 100, 14966–14969 (2003). Uses a mathematical model to analyse the evolutionary dynamics of cells in structured tissues.
  Article CAS PubMed PubMed Central Google Scholar
• Frank, S. A. Genetic predisposition to cancer — insights from population genetics. Nature Rev. Genet. 5, 764–772 (2004).
  Article CAS PubMed Google Scholar
• Fleming, M. A., Potter, J. D., Ramirez, C. J., Ostrander, G. K. & Ostrander, E. A. Understanding missense mutations in the BRCA1 gene: an evolutionary approach. Proc. Natl Acad. Sci. USA 100, 1151–1156 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Slatkin, M. & Rannala, B. Estimating allele age. Annu. Rev. Genomics Hum. Genet. 1, 225–249 (2000).
  Article CAS PubMed Google Scholar
• Deng, C. X. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 34, 1416–1426 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Jernstrom, H., Johannsson, O., Borg, A., Ivarsson, H. & Olsson, H. BRCA1-positive patients are small for gestational age compared with their unaffected relatives. Eur. J. Cancer 34, 368–371 (1998).
  Article CAS PubMed Google Scholar
• Smith, T. M. et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res. 6, 1029–1049 (1996).
  Article CAS PubMed Google Scholar
• Pavlicek, A. et al. Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer pre-disposition. Hum. Mol. Genet. 13, 2737–2751 (2004).
  Article CAS PubMed Google Scholar
• Summers, K. & Crespi, B. Cadherins in maternal–foetal interactions: red queen with a green beard? Proc. Biol. Sci. 272, 643–649 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Nielsen, R. et al. A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol. 3, e170 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Crespi, B. J. & Summers, K. Positive selection in the evolution of cancer. Biol. Rev. Camb. Philos. Soc. 81, 407–424 (2006).
  Article PubMed Google Scholar
• Hernandez, L., Kozlov, S., Piras, G. & Stewart, C. L. Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc. Natl Acad. Sci. USA 100, 13344–13349 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Moran, P. A. P. Random processes in genetics. Proc. Camb. Phil. Soc. 54, 60–71 (1958).
  Article Google Scholar
• Ewens, W. J. Mathematical Population Genetics (Springer-Verlag, New York, 2004).
  Book Google Scholar
• Reid, B. J. et al. Barrett's esophagus: ordering the events that lead to cancer. Euro. J. Cancer Prev. 5 (Suppl. 2), 57–65 (1996). Shows how spatial information can be used to infer dependencies between genetic alterations in carcinogenesis.
  Article Google Scholar
• Wang, G. Q. et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 54, 187–192 (2005).
  Article PubMed PubMed Central Google Scholar
• Reid, B. J. et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am. J. Gastroenterol. 96, 2839–2848 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Dolan, K., Morris, A. I., Gosney, J. R., Field, J. K. & Sutton, R. Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus. J. Gastroenterol. Hepatol. 18, 683–689 (2003).
  Article CAS PubMed Google Scholar
• Teodori, L. et al. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. Cytometry 34, 257–263 (1998).
  Article CAS PubMed Google Scholar
• Lee, J. J. et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin. Cancer Res. 6, 1702–1710 (2000).
  CAS PubMed Google Scholar
• Rosin, M. P. et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin. Cancer Res. 6, 357–362 (2000).
  CAS PubMed Google Scholar
• Befrits, R., Hammarberg, C., Rubio, C., Jaramillo, E. & Tribukait, B. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis. Colon. Rectum 37, 313–319; discussion 319–320 (1994).
  Article CAS PubMed Google Scholar
• Lofberg, R., Brostrom, O., Karlen, P., Tribukait, B. & Ost, A. Colonoscopic surveillance in long-standing total ulcerative colitis-a 15-year follow-up study. Gastroenterology 4, 1021–1021 (1990).
  Article Google Scholar
• Wong, B. C. et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291, 187–194 (2004).
  Article CAS PubMed Google Scholar
• Thompson, I. M. et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 349, 215–224 (2003).
  Article CAS PubMed Google Scholar
• Abrams, P. A. On classifying interactions between populations. Oecologia 73, 272–281 (1987).
  Article CAS PubMed Google Scholar
• Heppner, G. H., Miller, B. E. & Miller, F. R. Tumor subpopulation interactions in neoplasms. Biochim. Biophys. Acta 695, 215–226 (1983).
  CAS PubMed Google Scholar